CytomX Therapeutics Inc (CTMX) earnings · rev $76.2M
These earnings events as JSON? API free 100/dayCytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
This CTMX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CTMX revenue for 2025-12-31 was $76.2M. Net income was -$17.4M. Revenue was down 44.8% from 2024-12-31 to 2025-12-31. CTMX currently screens at market cap $653.1M.
When the next CTMX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 44.8% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full CTMX research stays on the stock page; the tape stays on the quote page.
CTMX earnings FAQ
What are CTMX's latest revenue and net income?
Latest cached CytomX Therapeutics Inc (CTMX) revenue for Dec 31, 2025 was $76.2M. Net income was -$17.4M. Statements: https://lician.com/financials/ctmx
What period does the latest CTMX earnings print cover?
The latest cached CytomX Therapeutics Inc (CTMX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did CTMX revenue change from the prior cached period?
Cached CytomX Therapeutics Inc (CTMX) revenue was down 44.8% from $138.1M (Dec 31, 2024) to $76.2M (Dec 31, 2025). Statements: https://lician.com/financials/ctmx
Where are CTMX earnings listed?
Cached earnings facts for CytomX Therapeutics Inc (CTMX) are listed at https://lician.com/earnings/ctmx. Statements: https://lician.com/financials/ctmx
Not investment advice.